Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

INSPIRE Pipeline™ Shield Post Approval Study

ClinicalTrials.gov ID: NCT05071963

Public ClinicalTrials.gov record NCT05071963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:00 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Neurovascular Product Surveillance Registry (INSPIRE) Pipeline™ Flex Embolization Device With Shield Technology™ Post Approval Study (PAS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.

Study identification

NCT ID
NCT05071963
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Enrollment
246 participants

Conditions and interventions

Eligibility (public fields only)

Age range
22 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2021 (Actual)
Primary completion
Jan 2027 (Estimated)
Completion
Apr 2028 (Estimated)
Last update posted
Aug 10, 2026

2021 – 2028

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
15
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
Yale New Haven Hospital New Haven Connecticut 06510 —
Baptist Medical Center Jacksonville Jacksonville Florida 32207 —
Emory University Hospital Atlanta Georgia 30322 —
Endeavor Health - Evanston Hospital Evanston Illinois 60201 —
Norton Healthcare Louisville Kentucky 40202 —
Washington University in Saint Louis St Louis Missouri 63130 —
NYU Langone Medical Center New York New York 10016-6402 —
Montefiore Medical Center New York New York 10467-2401 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
Oklahoma (OU) University Medical Center Oklahoma City Oklahoma 73104 —
Geisinger Medical Center Danville Pennsylvania 17822-9800 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Prisma Health Greenville South Carolina 29605 —
Baylor Scott & White Research Institute Dallas Texas 75201 —
University of Utah Hospital Salt Lake City Utah 84132-0001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05071963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05071963 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →